scholarly journals The role of managed care pharmacy in coprescribing naloxone for patients with specific risk: recommendations from the AMCP Addiction Advisory Group

2022 ◽  
Vol 28 (1) ◽  
pp. 100-106
Author(s):  
Jann B Skelton ◽  
Vyishali Dharbhamalla
Keyword(s):  
Managed Care ◽  
Advisory Group ◽  
Specific Risk

The Integral Role of Nursing in Managed Care

1996 ◽  
Vol 27 (4) ◽  
pp. 22???24
Author(s):  
ROSE BROWNE ◽  
KAREN BIANCOLILLO
Keyword(s):  
Managed Care ◽  
Integral Role ◽  
Role Of Nursing

Redistributing Investment in Health and Social Services—The Evolving Role of Managed Care

JAMA ◽  
2018 ◽  
Vol 320 (21) ◽  
pp. 2197 ◽  
Author(s):  
William H. Shrank ◽  
Donna J. Keyser ◽  
John G. Lovelace
Keyword(s):  
Managed Care ◽  
Social Services ◽  
Health And Social Services

scholarly journals Psycho-economics: managed care in mental health in the new millennium

2002 ◽  
Vol 25 (2) ◽  
pp. 199
Keyword(s):  
Mental Health ◽  
United States ◽  
Health Care ◽  
Managed Care ◽  
United States Of America ◽  
Private Practice ◽  
The United States ◽  
New Millennium

Book Review - Psycho-economics: managed care in mental health in the new millennium Edited by Robert D WeitzThis book comprises ten separately authored chapters on the general theme of managed care, and the way that it has affected mental health care in the United States of America. The main focus is on the role of the psychologist in private practice.

The Role of Transfusion Medicine Physicians

1999 ◽  
Vol 123 (8) ◽  
pp. 663-667
Author(s):  
James P. AuBuchon
Keyword(s):  
Health Care ◽  
Managed Care ◽  
Transfusion Medicine ◽  
Management Skills ◽  
Patient Benefit ◽  
Laboratory Management ◽  
Financial Gain ◽  
Clinical Consultation

Abstract Physicians with interest or expertise in transfusion medicine must apply their clinical consultation and laboratory management skills to be accorded support for their activities. To establish credibility, efforts must initially be directed where patient benefit and financial gain can be documented. Focusing efforts on practice improvements and sharing the results of those efforts with physician colleagues and administrators can help ensure continued support. Transfusion medicine continues to play an important role in health care, particularly in an era of managed care and reduced resources. Investment in the activities of this discipline will pay off for patients, clinicians, and hospitals.

scholarly journals The Role of Medical Evidence in Managed Care Decisions

2000 ◽  
Vol 7 (5) ◽  
pp. 462-468
Author(s):  
Derek van Amerongen
Keyword(s):  
Managed Care ◽  
Medical Evidence

Role of a central laboratory in implementing national cholesterol education panel guidelines in rural practices: model system for managed care

1995 ◽  
Vol 41 (2) ◽  
pp. 271-274 ◽  
Author(s):  
R G Reed ◽  
S Y Fong ◽  
T A Pearson
Keyword(s):  
New York ◽  
Managed Care ◽  
Treatment Program ◽  
Registered Dietitian ◽  
Central Laboratory ◽  
Treatment Protocols ◽  
Center Staff ◽  
Upstate New York ◽  
National Cholesterol Education Panel

Abstract We describe the use of a central laboratory to identify patients who may be candidates for a hypercholesterolemia treatment program and to direct their referral into this program. The laboratory, providing service for 16 medical practices in a rural area of upstate New York, served as the entry point to the treatment program for those patients with serum cholesterol > or = 5.18 mmol/L. This treatment program, designed to follow the National Cholesterol Education Program Adult Treatment Panel Guidelines, was provided by the lipid referral center staff, including a registered dietitian and a lipid specialist. After introduction of this program, 52% of eligible patients received nutritional counseling for hypercholesterolemia, compared with only 29% in usual care settings. This program represents an enhanced role for laboratories in the implementation of treatment protocols typical of those adopted by managed care networks.

The Role of Professional Advocate in Endoscopy: The A-Equip Model

2020 ◽  
Vol 18 (Sup8) ◽  
pp. S18-S24
Author(s):  
Loraine Chenai Mahachi
Keyword(s):  
Quality Improvement ◽  
Clinical Supervision ◽  
Workforce Education ◽  
Advisory Group ◽  
Self Awareness ◽  
The Face ◽  
Human And Social Capital ◽  
Tools And Techniques ◽  
Clinical Audits

In endoscopy, quality improvement (QI) is paramount and integral to Joint Advisory Group (JAG) accreditation. The challenge is to keep staff engaged and enthused in the face of factors that influence their emotions and behaviour. This was demonstrated in the author's endoscopy recovery units being used to cope with an inpatient surge for 14 months, which increased stress, sickness and turnover and lowered compliance with clinical audits. The professional advocate (PA) was tasked with addressing this and established that the QI systems in place were inadequate without investment in the team's human and social capital. The PA acted according to the Advocating and Educating for Quality Improvement (A-EQUIP) model to create a positive environment and support continuous improvement using various wellbeing tools and techniques. Restorative clinical supervision, human factors training and concepts from neurological and social sciences were employed to increase self-awareness, improve attitudes and build resilience in the workforce. These techniques have received positive feedback and become integral to the service. Endoscopy services should prioritise investment in workforce education and wellbeing and adopt the role of PA, which should be considered as part of JAG workforce standards.

scholarly journals To CAG or not to CAG? Difficulties in determining submission to the Confidentiality Advisory Group: a commentary

2020 ◽  
pp. 174701612092006
Author(s):  
V Ranieri ◽  
H Stynes ◽  
E Kennedy
Keyword(s):  
Informed Consent ◽  
Health Research ◽  
Local Information ◽  
Advisory Group ◽  
Primary Role ◽  
The Public ◽  
Confidential Data ◽  
Information Governance ◽  
Group A

The Confidentiality Advisory Group (CAG) is a specialised body that advises the Health Research Authority (HRA) and the Secretary of State for Health on requests for access to confidential information, in the absence of informed consent from its owners. Its primary role is to oversee the safe use of such information and to counsel the governing bodies mentioned above as to whether such use is appropriate or inappropriate. Researchers who seek access to England or Wales-based confidential data, for medical purposes that are in the interest of the public, are typically required to submit an application to this body. However, it is not always clear to researchers whether requests for access to patient data fit within the remit of the CAG or a Trust’s local information governance team. This commentary will, therefore, explore the role of the CAG and reflect on how best to support researchers with this question.

Pharmacists’ Role in the Management of Acute and Recurrent Pericarditis: Inpatient and Outpatient Perspectives

2019 ◽  
Vol 33 (6) ◽  
pp. 838-845
Author(s):  
Nicholas C. Schwier
Keyword(s):  
Managed Care ◽  
Adverse Drug Events ◽  
Care Transitions ◽  
Practice Setting ◽  
Recurrent Pericarditis ◽  
Integral Role ◽  
Specialty Practice ◽  
Outpatient Practice ◽  
The Cost

Pharmacists are qualified to provide valued care to patients inflicted with cardiovascular-related disorders. Although the role of pharmacists regarding the care of patients with cardiovascular disease has been previously described, there is currently no literature describing the role of pharmacists in the management of patients with pericarditis, specifically in patients with viral or idiopathic etiologies of pericarditis. Much of the management of idiopathic pericarditis, whether acute or recurrent, is a combination of pharmacotherapy, consisting of aspirin, nonsteroidal anti-inflammatory therapies, colchicine, corticosteroids, and/or immunotherapies. Therefore, pharmacists in any practice setting (ie, inpatient or outpatient) have the opportunity to provide an integral role in ensuring adherence to guideline-based care related to the management of acute or recurrent idiopathic pericarditis, optimizing patients’ use of pharmacotherapy, preventing adverse drug events such as drug–drug and drug–disease interactions, resolving managed care-related issues, providing care transitions activities that emphasize medication reconciliation and patient education, and evaluating the cost-effectiveness of the pharmacotherapies used to treat acute and recurrent idiopathic pericarditis. This review describes the role of pharmacists in the management of acute and recurrent idiopathic pericarditis within the inpatient and outpatient practice settings, with an emphasis on specialty practice areas, such as the emergency department, intensive care and medicine units within the hospital, ambulatory care–based practices, community pharmacy, and managed care pharmacy.

scholarly journals The Relationship between Tuberculosis and Influenza Death during the Influenza (H1N1) Pandemic from 1918-19

2012 ◽  
Vol 2012 ◽  
pp. 1-9 ◽  
Author(s):  
Welling Oei ◽  
Hiroshi Nishiura
Keyword(s):  
Case Fatality ◽  
H1n1 Pandemic ◽  
Period Function ◽  
Specific Risk ◽  
Age Dependent ◽  
The Relationship ◽  
Shaped Pattern ◽  
Epidemiological Information ◽  
Influenza H1n1

The epidemiological mechanisms behind the W-shaped age-specific influenza mortality during the Spanish influenza (H1N1) pandemic 1918-19 have yet to be fully clarified. The present study aimed to develop a formal hypothesis: tuberculosis (TB) was associated with the W-shaped influenza mortality from 1918-19. Three pieces of epidemiological information were assessed: (i) the epidemic records containing the age-specific numbers of cases and deaths of influenza from 1918-19, (ii) an outbreak record of influenza in a Swiss TB sanatorium during the pandemic, and (iii) the age-dependent TB mortality over time in the early 20th century. Analyzing the data (i), we found that the W-shaped pattern was not only seen in mortality but also in the age-specific case fatality ratio, suggesting the presence of underlying age-specific risk factor(s) of influenza death among young adults. From the data (ii), TB was shown to be associated with influenza death (P=0.09), and there was no influenza death among non-TB controls. The data (iii) were analyzed by employing the age-period-cohort model, revealing harvesting effect in the period function of TB mortality shortly after the 1918-19 pandemic. These findings suggest that it is worthwhile to further explore the role of TB in characterizing the age-specific risk of influenza death.

Sign in / Sign up

Export Citation Format

Share Document